203 related articles for article (PubMed ID: 16962577)
1. The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated.
Atack JR; Bayley PJ; Fletcher SR; McKernan RM; Wafford KA; Dawson GR
Eur J Pharmacol; 2006 Oct; 548(1-3):77-82. PubMed ID: 16962577
[TBL] [Abstract][Full Text] [Related]
2. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.
Atack JR; Bayley PJ; Seabrook GR; Wafford KA; McKernan RM; Dawson GR
Neuropharmacology; 2006 Nov; 51(6):1023-9. PubMed ID: 17046030
[TBL] [Abstract][Full Text] [Related]
3. [3H]RY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits.
Skolnick P; Hu RJ; Cook CM; Hurt SD; Trometer JD; Liu R; Huang Q; Cook JM
J Pharmacol Exp Ther; 1997 Nov; 283(2):488-93. PubMed ID: 9353361
[TBL] [Abstract][Full Text] [Related]
4. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
[TBL] [Abstract][Full Text] [Related]
5. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
[TBL] [Abstract][Full Text] [Related]
6. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
[TBL] [Abstract][Full Text] [Related]
7. Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.
Pym LJ; Cook SM; Rosahl T; McKernan RM; Atack JR
Br J Pharmacol; 2005 Nov; 146(6):817-25. PubMed ID: 16184188
[TBL] [Abstract][Full Text] [Related]
8. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis.
Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM
J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
Atack JR; Maubach KA; Wafford KA; O'Connor D; Rodrigues AD; Evans DC; Tattersall FD; Chambers MS; MacLeod AM; Eng WS; Ryan C; Hostetler E; Sanabria SM; Gibson RE; Krause S; Burns HD; Hargreaves RJ; Agrawal NG; McKernan RM; Murphy MG; Gingrich K; Dawson GR; Musson DG; Petty KJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):470-84. PubMed ID: 19704033
[TBL] [Abstract][Full Text] [Related]
11. 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors.
Szekeres HJ; Atack JR; Chambers MS; Cook SM; Macaulay AJ; Pillai GV; MacLeod AM
Bioorg Med Chem Lett; 2004 Jun; 14(11):2871-5. PubMed ID: 15125950
[TBL] [Abstract][Full Text] [Related]
12. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
Atack JR
Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
[TBL] [Abstract][Full Text] [Related]
13. Rat pharmacokinetics and pharmacodynamics of a sustained release formulation of the GABAA alpha5-selective compound L-655,708.
Atack JR; Pike A; Clarke A; Cook SM; Sohal B; McKernan RM; Dawson GR
Drug Metab Dispos; 2006 May; 34(5):887-93. PubMed ID: 16455808
[TBL] [Abstract][Full Text] [Related]
14. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin.
Wang F; Xu Z; Ren L; Tsang SY; Xue H
Neuropharmacology; 2008 Dec; 55(7):1231-7. PubMed ID: 18723037
[TBL] [Abstract][Full Text] [Related]
15. 6,3'-Dinitroflavone is a low efficacy modulator of GABA(A) receptors.
Furtmueller R; Furtmueller B; Ramerstorfer J; Paladini AC; Wasowski C; Marder M; Huck S; Sieghart W
Eur J Pharmacol; 2008 Sep; 591(1-3):142-6. PubMed ID: 18639544
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors.
Liu R; Hu RJ; Zhang P; Skolnick P; Cook JM
J Med Chem; 1996 Apr; 39(9):1928-34. PubMed ID: 8627617
[TBL] [Abstract][Full Text] [Related]
17. A Benzodiazepine Ligand with Improved GABA
Simeone X; Koniuszewski F; Müllegger M; Smetka A; Steudle F; Puthenkalam R; Ernst M; Scholze P
Mol Pharmacol; 2021 Jan; 99(1):39-48. PubMed ID: 33268553
[TBL] [Abstract][Full Text] [Related]
18. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site.
Street LJ; Sternfeld F; Jelley RA; Reeve AJ; Carling RW; Moore KW; McKernan RM; Sohal B; Cook S; Pike A; Dawson GR; Bromidge FA; Wafford KA; Seabrook GR; Thompson SA; Marshall G; Pillai GV; Castro JL; Atack JR; MacLeod AM
J Med Chem; 2004 Jul; 47(14):3642-57. PubMed ID: 15214791
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist.
Li X; Cao H; Zhang C; Furtmueller R; Fuchs K; Huck S; Sieghart W; Deschamps J; Cook JM
J Med Chem; 2003 Dec; 46(26):5567-70. PubMed ID: 14667209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
